مقالات
شرکت داروسازی ابوریحان
Fingolimod in the treatment of relapsing–remitting multiple sclerosis long term experience and an update on the clinical evidence
Real-world evidence on the safety and effectiveness of fingolimod in patients with multiple sclerosis from Taiwan